SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-016553
Filing Date
2023-05-12
Accepted
2023-05-12 13:42:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 504313
2 form424b3_001.jpg GRAPHIC 6874
  Complete submission text file 0001493152-23-016553.txt   514960
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269442 | Film No.: 23914670
SIC: 2834 Pharmaceutical Preparations